Clinical Trial: A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07201064) titled 'A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma' on Sept. 23.

Brief Summary: This study is a "3+3" dose-escalation, open-label, multiple-dose clinical trial.

Study Start Date: Sept. 25

Study Type: INTERVENTIONAL

Condition: Advanced Hepatocellular Carcinoma

Intervention: DRUG: SZ1003 injection

once every two weeks at a dose of SZ1003 injection per infusion.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....